Dikmetaş, Ö. Et Al. 2020. The Value of Fortified Aminoglycoside/Cephalosporin Treatment as First-Line Treatment and in Fluoroquinolone-Resistant Bacterial Keratitis. Turkish journal of ophthalmology , vol.50, no.5 , 258-263.

Dikmetaş, Ö., Deniz, Y., Kocabeyoğlu, S., Başol, M., & İrkeç, M., (2020). The Value of Fortified Aminoglycoside/Cephalosporin Treatment as First-Line Treatment and in Fluoroquinolone-Resistant Bacterial Keratitis. Turkish journal of ophthalmology , vol.50, no.5, 258-263.

Dikmetaş, ÖZLEM Et Al. "The Value of Fortified Aminoglycoside/Cephalosporin Treatment as First-Line Treatment and in Fluoroquinolone-Resistant Bacterial Keratitis," Turkish journal of ophthalmology , vol.50, no.5, 258-263, 2020

Dikmetaş, ÖZLEM Et Al. "The Value of Fortified Aminoglycoside/Cephalosporin Treatment as First-Line Treatment and in Fluoroquinolone-Resistant Bacterial Keratitis." Turkish journal of ophthalmology , vol.50, no.5, pp.258-263, 2020

Dikmetaş, Ö. Et Al. (2020) . "The Value of Fortified Aminoglycoside/Cephalosporin Treatment as First-Line Treatment and in Fluoroquinolone-Resistant Bacterial Keratitis." Turkish journal of ophthalmology , vol.50, no.5, pp.258-263.

@article{article, author={ÖZLEM DİKMETAŞ Et Al. }, title={The Value of Fortified Aminoglycoside/Cephalosporin Treatment as First-Line Treatment and in Fluoroquinolone-Resistant Bacterial Keratitis}, journal={Turkish journal of ophthalmology}, year=2020, pages={258-263} }